PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Section of Clinical Biochemistry, Verona, Italy.\', \'John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA.\', \'Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, USA.\', \'Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.\', \'Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1515/cclm-2020-0727/j/cclm.2020.58.issue-9/cclm-2020-0727/cclm-2020-0727.xml
?:hasPublicationType
?:journal
  • Clinical chemistry and laboratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 32598305
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.114
?:rankingScore_hIndex
  • 88
is ?:relation_isRelatedTo_publication of
?:title
  • Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all